Alembic Pharmaceuticals shares under SEBI spotlight as DSP Trustee discloses acquisition
Why did Alembic Pharmaceuticals Ltd shares fall today?
Alembic Pharmaceuticals Ltd shares declined 0.82% to ₹847.2 by 11:48 AM on Tuesday. The modest dip followed the receipt of a disclosure by the company under the SEBI Takeover Regulations. This filing pertains to holdings involving DSP Trustee Private Ltd and other associated entities.
In simple terms, this disclosure indicates that DSP Trustee Private Ltd and others, which could include investment funds or clients they manage, have either acquired or now hold a substantial number of shares in Alembic Pharmaceuticals. Such filings are mandatory when an entity's stake in a listed company crosses certain threshold limits, often 5% or more.
This type of news is generally informational and does not inherently signal a negative event for the company. The share price movement suggests the market may be reacting to the update or to adjustments in portfolio allocations by these large investors, rather than any deterioration in the company's business fundamentals.
What does Alembic Pharmaceuticals Ltd do?
Alembic Pharmaceuticals Ltd is a company whose operations fall within the pharmaceutical sector. Based on the available information, the company is engaged in the pharmaceutical business.
No further details regarding its specific products, therapeutic areas, or operational scope are available within the context provided.
Alembic Pharmaceuticals Ltd Financials
In CroresAlembic Pharmaceuticals Ltd showed a mixed financial trend between March and June 2026. The company's revenue grew significantly from ₹1847.72 Crores to ₹2149.77 Crores, indicating a strong quarter-over-quarter increase. However, its profit decreased during the same period, falling from ₹202.7 Crores to ₹173.07 Crores. This data suggests a pattern where top-line expansion did not translate into bottom-line growth for the quarter ending June 2026.
Alembic Pharmaceuticals Ltd Shareholding Pattern
Promoter holding stands at 69.87% of the total share capital. Foreign Institutional Investors (FIIs) hold 4.17% stake in the company, while Domestic Institutional Investors (DIIs) hold 15.93%. Public shareholders hold the remaining 10.0% stake in Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd FAQs
Q: Why did Alembic shares fall 0.82% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Alembic Pharmaceuticals Ltd?
As per the latest data, promoters hold 69.87% stake in Alembic Pharmaceuticals Ltd, while FII holding stands at 4.17%. Domestic institutional investors hold 15.93%, and public shareholders account for 10.0% of the equity.
Q: What is the current stock price of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd shares are currently trading at ₹847.2, recording a decline of 0.82% from the previous close.
Q: What is the market capitalization of Alembic Pharmaceuticals Ltd?
The company currently has a market capitalization of ₹16652.83 crore, reflecting its valuation in the Indian equity market.